This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2024
Title: Liming Liu: Innovator in Fc-Containing Polypeptides
Introduction
Liming Liu is a notable inventor based in Ambler, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of Fc-containing polypeptides. With a total of 2 patents, his work focuses on enhancing the properties of these polypeptides for various applications.
Latest Patents
Liu's latest patents include innovative methods and compositions for producing Fc-containing polypeptides with improved properties. One of his patents is titled "Fc-containing polypeptides having improved properties and comprising mutations at positions 243 and 264 of the Fc-region." This invention outlines methods for creating polypeptides that exhibit enhanced characteristics due to specific mutations. Another patent, "Method for preparing antibodies having improved properties," further emphasizes his commitment to advancing antibody production techniques.
Career Highlights
Throughout his career, Liming Liu has been associated with Merck Sharp & Dohme Corp., where he has contributed to groundbreaking research and development in the field of biotechnology. His expertise in Fc-containing polypeptides has positioned him as a key player in the industry.
Collaborations
Liu has collaborated with esteemed colleagues such as Terrance A Stadheim and Dongxin Zha. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Liming Liu's work in the field of Fc-containing polypeptides showcases his dedication to innovation and improvement in biotechnology. His patents reflect a commitment to advancing the science of antibody production and enhancing the properties of polypeptides.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
